In contrast, in obesity there is reduced production of protective hormones such as adiponectin and ghrelin, both of which reduce breast cancer risk by inhibiting aromatase and other pathways associated with increased cancer cell proliferation (31, 32). Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.